Methods: The treatment group of program enrollees and the comparison group with no program contact were matched on 8 coarsened demographic, diagnosis, and severity variables associated with readmission risk. Assessed outcomes included relative risk and odds of readmission within 30 days post-discharge and overall within the 6-month evaluation period.
Results: Treatment group risk of readmission was 22% lower overall and 30-day readmission risk was 25% lower relative to the comparison group. Odds of any or 30-day readmission were 0.47 and 0.56, respectively, for treatment relative to comparison.
Conclusions: Participation in the CTS resulted in significantly lower rates of readmissions among patients with readmission-sensitive conditions, offering a scalable and sustainable approach to reduce the number of preventable hospital readmissions.